Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 January 2023 | Story Dr Cindé Greyling | Photo Anja Aucamp
Dr Nomalungelo Ngubane
Dr Nomalungelo Ngubane, the Director: Academy for Multilingualism, is working through various initiatives to ensure that the UFS becomes and remains the South African leader in multilingualism.

The Academy for Multilingualism was established at the beginning of 2021, flowing from the UFS Language Policy (2016) that is currently under review, and which expresses the university’s commitment to multilingualism, with a particular emphasis on Sesotho, Afrikaans, and isiZulu, while English remains the primary medium of instruction for undergraduate and postgraduate studies.

The Student Language Preference Survey continues to indicate that many students have difficulty understanding English lectures due to language differences. Multilingual models from places like South America, India and South Africa were considered in order to structure the approach at the UFS.

Promoting indigenous languages

To mitigate the English barrier, the academy is developing multilingual academic glossaries. The multilingual glossaries are also intended to drive the promotion of indigenous languages (Sesotho/Afrikaans/IsiZulu) as academic languages, and to create multilingual learning spaces that embrace diverse languages.

Academic word lists from seven departments are in the process of being translated – in conjunction with the Unit of Lexicography – to create glossaries. The team at South African Sign Languages will add videos to these glossaries to provide unique and inclusive content in the realm of multilingualism. 

In 2022, the academy, in collaboration with the Library and Information Services, launched an African Languages Press with the aim of promoting and advancing publications of literature and research books using South African indigenous languages. 

The Academy for Multilingualism also promotes multilingualism through the Initiative for Creative African Narratives (iCAN), a programme that encourages students to write short stories in their indigenous home languages. By incorporating student narratives into learning material, students learn about one another, from one another.

The iCAN multilingual booklets are also used to encourage extensive reading among undergraduates and among learners in the surrounding community schools.

Use of translanguaging practices
 
The academy is also working with the Centre for Teaching and Learning’s (CTL) A_STEP programme to pilot the use of translanguaging practices in tutor sessions. UFS staff will also be trained on teaching and translanguaging practices. Voice-over translations of English lessons into Afrikaans and Sesotho in the Faculty of Theology and Religion paved the way for the academy to proceed with this practice in other subjects. The Translanguaging Seminar 2022, hosted by the academy and the CTL, was used as a platform for sharing translanguaging knowledge and practices by academics from the UFS and other institutions.

The Kovsies Multilingual Mokete has become a popular annual tradition celebrating different cultural expressions – in visual art, poetry, storytelling, drama, music, and song – by different language groups and in the different languages that are dominant at the UFS (i.e. English, Afrikaans, Sesotho, isiZulu, and Sign Language). This year’s event was held on the South Campus in October.

With its various initiatives, the Academy for Multilingualism will ensure that the UFS becomes and remains the South African leader in multilingualism.

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept